Every Friday I do a gameplan look-ahead on “Mad Money.” It has to be cursory because I write about 1,200 words — which has to fit into one segment on television — that’s the typical structure/stricture. I can’t really dally on any particular earnings report because that means I won’t …
It was a wild week, with the bond market in the driver’s seat. Rising yields early on gave way to some moderation, and the Nasdaq hit an all-time high on Friday. The Nasdaq did not finish above its July record-high close of 18,647 but ended less than a half-percent away. …
When Tesla CFO Zachary Kirkhorn stepped down last August, Wall Street analysts and investors alike were unnerved. The stock shed more than $23 billion on the news, with one top tech analyst describing the announcement as “a blow in the near term” and a “big surprise to the Street.” It …
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future …
Earnings season is upon us. It’s more important than ever to do your homework. Wells Fargo on Friday was the first portfolio name to report third-quarter results, which have been greeted enthusiastically on Wall Street. The stock is trading back at early 2018 highs and extended its winning streak to …
Something different happened Friday – so different that it took my breath away. The first Friday of earnings season has recently been such a jumble of tension that we had forgotten what it’s like to have multiple big quarters reported in the morning. But that was exactly what we got. …